Effects of propylthiouracil on MHV-3 virus mouse hepatitis
De Marco, F.; Sabbatini, F.; D'Argenio, G.; Mazzacca, G.
Research Communications in Chemical Pathology and Pharmacology 35(1): 137-143
1982
ISSN/ISBN: 0034-5164 PMID: 6276952 Document Number: 186308
A study was undertaken to observe the effect of propylthiouracil (PTU) on MHV-3 virus mouse hepatitis. PTU-treatment adversely influenced the course of the hepatitis. This effect was reflected by a significantly higher mortality rate, in spite of the absence of any significant difference of the plasma transaminase activity increase and of the liver virus content.
Document emailed within 1 workday
Related Documents
Hirano, N.; Murakami, T.; Fujiwara, K.; Matsumoto, M. 1978: Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus Japanese Journal of Experimental Medicine 48(1): 71-75Smith, A.L.; Bottomly, K.; Winograd, D.F. 1987: Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus Journal of Immunology 138(10): 3426-3430
Maddrey, W.C. 1979: Propylthiouracil treatment of alcoholic hepatitis Gastroenterology 76(1): 218-219
Cofré, C.; Valdés, E.; Tapia, A.; Rodríguez, J. 1986: Cholestatic hepatitis secondary to propylthiouracil Revista Medica de Chile 114(1): 42-44
Mihas, A.A.; Holley, P.; Koff, R.S.; Hirschowitz, B.I. 1976: Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil Gastroenterology 70(5 Pt.1): 770-774
Fujiwara, K.; Tamura, T.; Hirano, N.; Takenaka, S. 1975: Mouse pancreas involvement in murine hepatitis virus infection Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 169(2): 477-480
Lamontagne, L.; Descoteaux, J.P.; Jolicoeur, P. 1989: Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity Journal of Immunology 142(12): 4458-4465
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Sutcliffe, S.; Taha, T.E.; Kumwenda, N.I.; Taylor, E.; Liomba, G.N. 2002: HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi Journal of Acquired Immune Deficiency Syndromes 31(1): 90-97
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Smith, M.S.; Click, R.E.; Plagemann, P.G. 1984: Control of mouse hepatitis virus replication in macrophages by a recessive gene on chromosome 7 Journal of Immunology 133(1): 428-432
Vassão, R.; Pereira, C.A. 1994: Antiviral activity of interferon gamma in vivo during mouse hepatitis virus infection Brazilian Journal of Medical and Biological Research 27(10): 2407-2411
Pereira, C.A.; Steffan, A.M.; Koehren, F.; Kirn, A. 1985: Inhibition of mouse hepatitis virus type 3 multiplication in activated Kupffer cells Brazilian Journal of Medical and Biological Research 18(4): 527-531
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Choi, Y.K.; Choi, J.Y.; Jeon, H.S.; Won, Y.S.; Lee, C.H.; Yoon, W.K.; Oh, G.T.; Hyun, B.H. 1999: Spontaneous low-virulence mouse hepatitis virus infection in severe combined immunodeficiency mice Laboratory Animal Science 49(3): 324-327
Casebolt, D.B.; Qian, B.; Stephensen, C.B. 1997: Detection of enterotropic mouse hepatitis virus fecal excretion by polymerase chain reaction Laboratory Animal Science 47(1): 6-10